Dichos y Refranes

Descargar Sj en PPS

Sj PPS

Sj: 10400 Libros PPS

  1. Ludwig Bonvin S.J.

     
    Tipo: Presentación Powerpoint
    Hadziyannis SJ et al. EASL. 2002. Peginterferon alfa-2a (40KD) (PEGASYS®) in combination with ribavirin (RBV): efficacy and safety results from a phase III, ... taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ....
    http://library.canisius.edu/documents/Archives/Bonvin/Bonvin%20presentation.ppt
  2.  
    Tipo: Presentación Powerpoint

  3. Download Figures (PPT)

     
    Tipo: Presentación Powerpoint
    Hadziyannis SJ et al. EASL. 2002. Peginterferon alfa-2a (40KD) (PEGASYS®) in combination with ribavirin (RBV): efficacy and safety results from a phase III, ... taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ....
    https://www.kidney-international.org/article/S0085-2538(15)52058-9/ppt

  4. Mitigating peritoneal membrane characteristics in modern peritoneal ...

     
    Tipo: Presentación Powerpoint
    Hadziyannis SJ et al. EASL. 2002. Peginterferon alfa-2a (40KD) (PEGASYS®) in combination with ribavirin (RBV): efficacy and safety results from a phase III, ... taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ....
    http://www.kidney-international.org/article/S0085-2538(15)51835-8/ppt

  5. Evidence of angiogenesis and microvascular regression in ...

     
    Tipo: Presentación Powerpoint
    Hadziyannis SJ et al. EASL. 2002. Peginterferon alfa-2a (40KD) (PEGASYS®) in combination with ribavirin (RBV): efficacy and safety results from a phase III, ... taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ....
    https://www.kidney-international.org/article/S0085-2538(15)52118-2/ppt?code=kint-site

  6. Charm Spectroscopy

     
    Tipo: Presentación Powerpoint
    Hadziyannis SJ et al. EASL. 2002. Peginterferon alfa-2a (40KD) (PEGASYS®) in combination with ribavirin (RBV): efficacy and safety results from a phase III, ... taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ....
    https://www.aps.org/meetings/multimedia/april2007/upload/E5_1.ppt

  7. PBS Environmental Risk Index

     
    Tipo: Presentación Powerpoint
    Hadziyannis SJ et al. EASL. 2002. Peginterferon alfa-2a (40KD) (PEGASYS®) in combination with ribavirin (RBV): efficacy and safety results from a phase III, ... taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ....
    https://ndiastorage.blob.core.usgovcloudapi.net/ndia/2004/enviro/sessions/session2/kennedy.ppt

  8. 7 Person FB Mechanics

     
    Tipo: Presentación Powerpoint
    Hadziyannis SJ et al. EASL. 2002. Peginterferon alfa-2a (40KD) (PEGASYS®) in combination with ribavirin (RBV): efficacy and safety results from a phase III, ... taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ....
    http://www.nsoa.org/wp-content/uploads/2014/03/7-Person-FB-Mechanics.pps

  9. taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ...

     
    Tipo: Presentación Powerpoint
    Hadziyannis SJ et al. EASL. 2002. Peginterferon alfa-2a (40KD) (PEGASYS®) in combination with ribavirin (RBV): efficacy and safety results from a phase III, ... taken with PEGASYS ® Hadziyannis SJ et al. EASL. 2002. Study ....
    http://www.natap.org/2002/easl/slideShow/942peg.ppt%201

Libro en otros formatos:


Arriba